the event any term of this Agreement conflicts with a term of the
Engagement Agreement, the term in this Agreement shall control.
26.3 This Agreement may be modified only by written amendment duly executed by
the Parties.
26.4 Intentionally left blank.
CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS DOCUMENT.
[***] INDICATES INFORMATION THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL
TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED INFORMATION HAS BEEN FILED
SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406
PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
In witness whereof, the Parties have executed this Agreement in duplicate
originals by their respective authorized officers or representatives on the
respective dates below.
Licensor: Analog Biosciences, Inc.
Licensee: Artelo Biosciences, Inc.
/s/ Joshua Schoonover
/s/ Gregory Gorgas
Authorized Signatory: Joshua S. Schoonover
Authorized Signatory: Gregory Gorgas
Date: May 2, 2017
Date: May 2, 2017